Preferred Label : Personalized Polyepitope Plasmid DNA Breast Cancer Vaccine;
NCIt definition : A polyepitope DNA vaccine composed of a DNA plasmid encoding multiple, highly immunogenic
tumor associated antigens (TAAs) that are specifically selected after genome profiling
of the patient's breast cancer cells, with potential immunostimulatory and antineoplastic
activities. Upon intramuscular administration and electroporation of the personalized
polyepitope plasmid DNA breast cancer vaccine, the expressed TAAs induce cytotoxic
T-lymphocyte (CTL) immune responses against tumor cells expressing the TAAs.;
Origin ID : C120306;
UMLS CUI : C3897937;
Semantic type(s)
- concept_is_in_subset
